IMR Assessment in Patients With New Diagnosis of Left Ventricle Dilatation
NCT ID: NCT02705170
Last Updated: 2018-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
35 participants
OBSERVATIONAL
2016-03-31
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AccuIMR Predicts Microvascular Obstruction and Infarct Size in STEMI Patients
NCT06947564
Angio-IMR and Cardiac MR-derived MVO in STEMI Patients
NCT04828681
MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery Disease
NCT01236807
CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF
NCT06316661
Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study
NCT06039748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients will undergo coronary artery angiography. To be enrolled, it is necessary to have the absence of significant coronary artery stenosis (angiographic evaluation of the lesion \>40%) in all the vessels (main and side branch).
The Authors will proceed to perform the evaluation of the index of microvascular resistance (IMR). The target vessel will be the left anterior descending artery.
An intracoronary pressure/temperature sensor-tipped guidewire will be used. Thermodilution curves will be obtained during maximal hyperemia. The IMR will be calculated from the ratio of the mean distal coronary pressure at maximal hyperemia to the inverse of mean hyperemic transit time.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
left ventricle dilatation
The subjects of the investigation will be patients with recent diagnosis of unknown left ventricle dilatation. These subjects received coronary artery angiography as exam suggested by guidelines to discriminate the cause of left ventricle dilatation. In subjects without documentation of coronary artery lesions, the Authors will assess the index of microvascular resistance.
index of microvascular resistance
Measurement of the index of microvascular resistance in the left anterior descending artery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
index of microvascular resistance
Measurement of the index of microvascular resistance in the left anterior descending artery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* absence of significant (\>40%) coronary artery disease at coronary artery angiography
Exclusion Criteria
* history of significant valvular disease
* contraindication to hyperemic agent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital of Ferrara
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gianluca Campo
Assistant Professor, Interventional Cardiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gianluca Campo, MD
Role: PRINCIPAL_INVESTIGATOR
Azienda Ospedaliera Universitaria di Ferrara
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Ferrara
Cona, Ferrara, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
260480
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.